The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Inhibition of Erythromycin and Erythromycin-Induced Resistance among Staphylococcus aureus Clinical Isolates
Abstract
The increasing incidence of erythromycin and erythromycin-induced resistance to clindamycin among Staphylococcus aureus (S. aureus) is a serious problem. Patients infected with inducible resistance phenotypes may fail to respond to clindamycin. This study aimed to identify the prevalence of erythromycin and erythromycin-induced resistance and assess for potential inhibitors. A total of 99 isolates were purified from various clinical sources. Phenotypic detection of macrolide-lincosamide-streptogramin B (MLSB)-resistance phenotypes was performed by D-test. MLSB-resistance genes were identified using PCR. Different compounds were tested for their effects on erythromycin and inducible clindamycin resistance by broth microdilution and checkerboard microdilution methods. The obtained data were evaluated using docking analysis. Ninety-one isolates were S. aureus. The prevalence of constitutive MLSB, inducible MLSB, and macrolide-streptogramin (MS) phenotypes was 39.6%, 14.3%, and 2.2%, respectively. Genes including ermC, ermA, ermB, msrA, msrB, lnuA, and mphC were found in 82.6%, 5.8%, 7.7%, 3.8%, 3.8%, 13.5%, and 3.8% of isolates, respectively. Erythromycin resistance was significantly reduced by doxorubicin, neomycin, and omeprazole. Quinine, ketoprofen, and fosfomycin combated and reversed erythromycin/clindamycin-induced resistance. This study highlighted the significance of managing antibiotic resistance and overcoming clindamycin treatment failure. Doxorubicin, neomycin, omeprazole, quinine, ketoprofen, and fosfomycin could be potential inhibitors of erythromycin and inducible clindamycin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The most common resistance mechanism involves methylation of the 23S rRNA component of the 50S ribosome, encoded by the erm(A) and erm(C) genes, which confer resistance to macrolides, lincosamides, and streptogramin B (MLS_B resistance) by preventing macrolide binding [262,263,264,265,266].”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [264]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Magiorakos, A.-P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, B., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03570.x · Cited by 14,449
Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192
David, M. Z., & Daum, R. S. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00081-09 · Cited by 1,972
Research works printed but not linked: 104
- Bitrus, 2018, Staphylococcus aureus: A review of antimicrobial resistance mechanisms, Vet. Sci. Res. J., 4, 43
- Fetsch, A. (2018). Staphylococcus Aureus, Elsevier. [1st ed.].
- Che Hamzah, A.M., Yeo, C.C., Puah, S.M., Chua, K.H., and Chew, C.H. (2019). Staphylococcus aureus infections in Malaysia: A review of antimicrobial resistance and characteristics of the clinical isolates, 1990–2017. Antibiotics, 8. · DOI
- Connolly, 2017, Identification of Staphylococcus aureus factors required for pathogenicity and growth in human blood, Infect. Immun., 85, e00337-17, 10.1128/IAI.00337-17 · DOI
- Schönfeld, W., and Kirst, H.A. (2002). Macrolide Antibiotics, Springer Science & Business Media. · doi:10.1007/978-3-0348-8105-0
- Roberts, 1999, Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants, Antimicrob. Agents Chemother., 43, 2823, 10.1128/AAC.43.12.2823 · DOI · Paper page
- Aktas, 2007, Resistance to macrolide, lincosamide and streptogramin antibiotics in staphylococci isolated in Istanbul, Turkey, J. Microbiol., 45, 286
- Reynolds, 2003, Msr (A) and related macrolide/streptogramin resistance determinants: Incomplete transporters?, Int. J. Antimicrob. Agents, 22, 228, 10.1016/S0924-8579(03)00218-8 · DOI
- Luna, 1999, A variety of gram-positive bacteria carry mobile mef genes, J. Antimicrob. Chemother., 44, 19, 10.1093/jac/44.1.19 · DOI · Paper page
- Matsuoka, 2003, Characteristic expression of three genes, msr (A), mph (C) and erm (Y), that confer resistance to macrolide antibiotics on Staphylococcus aureus, FEMS Microbiol. Lett., 220, 287, 10.1016/S0378-1097(03)00134-4 · DOI
- Zelazny, 2005, Selection of strains for quality assessment of the disk induction method for detection of inducible clindamycin resistance in staphylococci: A CLSI collaborative study, J. Clin. Microbiol., 43, 2613, 10.1128/JCM.43.6.2613-2615.2005 · doi:10.1128/jcm.43.6.2613-2615.2005
- Leclercq, 2002, Mechanisms of resistance to macrolides and lincosamides: Nature of the resistance elements and their clinical implications, Clin. Infect. Dis., 34, 482, 10.1086/324626 · DOI · Paper page
- Saribas, 2006, Prevalence of erm genes encoding macrolide-lincosamide-streptogramin (MLS) resistance among clinical isolates of Staphylococcus aureus in a Turkish university hospital, Clin. Microbiol. Infect., 12, 797, 10.1111/j.1469-0691.2006.01486.x · doi:10.1111/j.1469-0691.2006.01486.x
- Lina, 1999, Distribution of genes encoding resistance to macrolides, lincosamides, and streptogramins among staphylococci, Antimicrob. Agents Chemother., 43, 1062, 10.1128/AAC.43.5.1062 · DOI · Paper page
- Ounissi, 1985, Nucleotide sequence of the gene ereA encoding the erythromycin esterase in Escherichia coli, Gene, 35, 271, 10.1016/0378-1119(85)90005-8 · DOI
- Chesneau, 2007, Resistance phenotypes conferred by macrolide phosphotransferases, FEMS Microbiol. Lett., 269, 317, 10.1111/j.1574-6968.2007.00643.x · DOI
- Delrieu, 1988, Inactivation of lincosaminide antibiotics in Staphylococcus. Identification of lincosaminide O-nucleotidyltransferases and comparison of the corresponding resistance genes, J. Biol. Chem., 263, 15880, 10.1016/S0021-9258(18)37532-X · DOI
- Allignet, 1999, Comparative analysis of staphylococcal plasmids carrying three streptogramin-resistance genes: vat–vgb–vga, Plasmid, 42, 134, 10.1006/plas.1999.1412 · DOI
- Daurel, 2008, Differences in potential for selection of clindamycin-resistant mutants between inducible erm (A) and erm (C) Staphylococcus aureus genes, J. Clin. Microbiol., 46, 546, 10.1128/JCM.01925-07 · doi:10.1128/jcm.01925-07
- Drinkovic, 2001, Clindamycin treatment of Staphylococcus aureus expressing inducible clindamycin resistance, J. Antimicrob. Chemother., 48, 315, 10.1093/jac/48.2.315 · DOI · Paper page
- Siberry, 2003, Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro, Clin. Infect. Dis., 37, 1257, 10.1086/377501 · DOI · Paper page
- Gould, 2009, Antibiotic resistance: The perfect storm, Int. J. Antimicrob. Agents, 34, S2, 10.1016/S0924-8579(09)70549-7 · doi:10.1016/s0924-8579(09)70549-7
- Clancy, 1995, Assays to detect and characterize synthetic agents that inhibit the ErmC methyltransferase, J. Antibiot., 48, 1273, 10.7164/antibiotics.48.1273 · doi:10.7164/antibiotics.48.1273
- Ahirrao, 2020, MsrA efflux pump inhibitory activity of Piper cubeba lf and its phytoconstituents against Staphylococcus aureus RN4220, Chem. Biodivers., 17, e2000144, 10.1002/cbdv.202000144 · DOI
- Figueredo, 2021, Inhibition of Staphylococcus aureus TetK and MsrA efflux pumps by hydroxyamines derived from lapachol and norlachol, J. Bioenerg. Biomembr., 53, 149, 10.1007/s10863-021-09885-5 · DOI
- Smith, 2007, The phenolic diterpene totarol inhibits multidrug efflux pump activity in Staphylococcus aureus, Antimicrob. Agents Chemother., 51, 4480, 10.1128/AAC.00216-07 · DOI
- Fung, 2017, Synergists from Portulaca oleracea with macrolides against methicillin-resistant Staphylococcus aureus and related mechanism, Hong Kong Med. J., 23, 38
- Kaatz, 1993, Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus, Antimicrob. Agents Chemother., 37, 1086, 10.1128/AAC.37.5.1086 · DOI · Paper page
- Saber, 2018, The inhibitory effect of fluphenazinedecanoate and caffeine on Staphylococcus aureus efflux pumps, Curr. Res. Microbiol. Biotechnol., 6, 1530
- Kumar, 2008, Novel structural analogues of piperine as inhibitors of the NorA efflux pump of Staphylococcus aureus, J. Antimicrob. Chemother., 61, 1270, 10.1093/jac/dkn088 · DOI · Paper page
- Vidaillac, 2007, Synthesis of omeprazole analogues and evaluation of these as potential inhibitors of the multidrug efflux pump NorA of Staphylococcus aureus, Antimicrob. Agents Chemother., 51, 831, 10.1128/AAC.01306-05 · DOI
- Tintino, 2016, Action of cholecalciferol and alpha-tocopherol on Staphylococcus aureus efflux pumps, EXCLI J., 15, 315
- Tintino, 2018, Vitamin K enhances the effect of antibiotics inhibiting the efflux pumps of Staphylococcus aureus strains, Med. Chem. Res., 27, 261, 10.1007/s00044-017-2063-y · DOI
- Aeschlimann, 1999, Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus, Antimicrob. Agents Chemother., 43, 335, 10.1128/AAC.43.2.335 · doi:10.1128/aac.43.2.335
- Bharate, 2015, Discovery of 4-acetyl-3-(4-fluorophenyl)-1-(p-tolyl)-5-methylpyrrole as a dual inhibitor of human P-glycoprotein and Staphylococcus aureus Nor A efflux pump, Org. Biomol. Chem., 13, 5424, 10.1039/C5OB00246J · DOI
- Blanchard, 2016, Neomycin sulfate improves the antimicrobial activity of mupirocin-based antibacterial ointments, Antimicrob. Agents Chemother., 60, 862, 10.1128/AAC.02083-15 · DOI
- Rumynska, 2021, Microbial biofilms and some aspects of anti-inflammatory drug use, Biopolym. Cell, 37, 247, 10.7124/bc.000A57 · DOI
- Khalaf, 2015, Antibacterial, anti-biofilm activity of some non-steroidal anti-inflammatory drugs and N-acetyl cysteine against some biofilm producing uropathogens, Am. J. Epidemiol., 3, 1
- Oselin, 2007, Inhibition of human thiopurine S-methyltransferase by various nonsteroidal anti-inflammatory drugs in vitro: A mechanism for possible drug interactions, Drug Metab. Dispos., 35, 1452, 10.1124/dmd.107.016287 · doi:10.1124/dmd.107.016287
- Abreu, 2016, Combinatorial approaches with selected phytochemicals to increase antibiotic efficacy against Staphylococcus aureus biofilms, Biofouling, 32, 1103, 10.1080/08927014.2016.1232402 · DOI
- Olateju, 2021, Quinoline antimalarials increase the antibacterial activity of ampicillin, Front. Microbiol., 12, 556550, 10.3389/fmicb.2021.556550 · DOI
- Bodet, 1985, Antibacterial activities of antineoplastic agents, Antimicrob. Agents Chemother., 28, 437, 10.1128/AAC.28.3.437 · DOI
- Peiris, 1993, Antimicrobial activity of cytotoxic drugs may influence isolation of bacteria and fungi from blood cultures, J. Clin. Pathol., 46, 1124, 10.1136/jcp.46.12.1124 · DOI
- Gieringer, 1986, Effect of 5-fluorouracil, mitoxantrone, methotrexate, and vincristine on the antibacterial activity of ceftriaxone, ceftazidime, cefotiam, piperacillin, and netilmicin, Chemotherapy, 32, 418, 10.1159/000238445 · doi:10.1159/000238445
- Yokochi, 2004, Doxorubicin inhibits DNMT1, resulting in conditional apoptosis, Mol. Pharmacol., 66, 1415, 10.1124/mol.104.002634 · doi:10.1124/mol.104.002634
- Schlievert, 2021, Staphylococcal Enterotoxin C Subtypes Are Differentially Associated with Human Infections and Immunobiological Activities, mSphere, 6, e01153-20, 10.1128/mSphere.01153-20 · doi:10.1128/msphere.01153-20
- Mehraj, 2016, Epidemiology of Staphylococcus aureus nasal carriage patterns in the community, Curr. Top. Microbiol. Immunol., 398, 55
- Kuehl, 2020, When antibiotics fail: A clinical and microbiological perspective on antibiotic tolerance and persistence of Staphylococcus aureus, J. Antimicrob. Chemother., 75, 1071, 10.1093/jac/dkz559 · DOI
- Razeghi, 2019, Incidence of inducible clindamycin resistance and antibacterial resistance genes variability in clinical Staphylococcus aureus strains: A two-year multicenter study in Tehran, Iran, Gene Rep., 16, 100411, 10.1016/j.genrep.2019.100411 · DOI
- Ahmed, 2011, Nosocomial vancomycin and methicillin resistant staphylococcal infections in intensive care units in Assiut University Hospitals, Egypt. J. Med. Microbiol., 20, 127
- Isturiz, 2009, Epidemiology of meticillin-resistant Staphylococcus aureus (MRSA) in Latin America, Int. J. Antimicrob. Agents, 34, 304, 10.1016/j.ijantimicag.2009.06.005 · DOI
- Jiménez Quiceno, J.N., Ocampo Ríos, A.M., Vanegas Múnera, J.M., Rodríguez Tamayo, E.A., Mediavilla, J., Chen, L., Muskus, C., Vélez, L., Rojas, C., and Restrepo Gouzy, A. (2012). CC8 MRSA strains harboring SCCmec Type IVc are predominant in Colombian hospitals. PLoS ONE, 7. · DOI
- Youssef, 2021, The alarming association between antibiotic resistance and reduced susceptibility to biocides in nosocomial MRSA isolates from two regional hospitals in Egypt, Arch. Microbiol., 203, 3295, 10.1007/s00203-021-02314-6 · doi:10.1007/s00203-021-02314-6
- Kishk, 2020, Inducible clindamycin resistance in clinical isolates of staphylococcus aureus in Suez Canal University Hospital, Ismailia, Egypt, J. Infect. Dev. Ctries., 14, 1281, 10.3855/jidc.12250 · doi:10.3855/jidc.12250
- Adhikari, R., Shrestha, S., Barakoti, A., and Amatya, R. (2017). Inducible clindamycin and methicillin resistant Staphylococcus aureus in a tertiary care hospital, Kathmandu, Nepal. BMC Infect. Dis., 17. · DOI
- Majhi, 2016, Detection of inducible and constitutive clindamycin resistance among Staphylococcus aureus isolates in a tertiary care hospital, Eastern India, Avicenna J. Med., 6, 75, 10.4103/2231-0770.184066 · doi:10.4103/2231-0770.184066
- Hamzah, 2019, Tigecycline and inducible clindamycin resistance in clinical isolates of methicillin-resistant Staphylococcus aureus from Terengganu, Malaysia, J. Med. Microbiol., 68, 1299, 10.1099/jmm.0.000993 · DOI
- Jarajreh, 2017, Prevalence of inducible clindamycin resistance in methicillin-resistant Staphylococcus aureus: The first study in Jordan, J. Infect. Dev. Ctries., 11, 350, 10.3855/jidc.8316 · doi:10.3855/jidc.8316
- Sarrou, 2019, MLSB-resistant Staphylococcus aureus in central Greece: Rate of resistance and molecular characterization, Microb. Drug Resist., 25, 543, 10.1089/mdr.2018.0259 · doi:10.1089/mdr.2018.0259
- Mama, 2019, Methicillin-and inducible clindamycin-resistant Staphylococcus aureus among patients with wound infection attending Arba Minch Hospital, South Ethiopia, Int. J. Microbiol., 2019, 2965490, 10.1155/2019/2965490 · doi:10.1155/2019/2965490
- Maravic, 2004, Macrolide resistance based on the Erm-mediated rRNA methylation, Curr. Drug Targets Infect. Disord., 4, 193, 10.2174/1568005043340777 · DOI
- Elkammoshi, 2016, A low prevalence of inducible macrolide, lincosamide, and streptogramin b resistance phenotype among methicillin-susceptible Staphylococcus aureus isolated from malaysian patients and healthy individuals, Jundishapur J. Microbiol., 9, e37148
- Pereira, 2016, Phenotypic and molecular characterization of resistance to macrolides, lincosamides and type B streptogramin of clinical isolates of Staphylococcus spp. of a university hospital in Recife, Pernambuco, Brazil, Braz. J. Infect. Dis., 20, 276, 10.1016/j.bjid.2016.03.003 · DOI
- Cabrera, 2020, Molecular characterization of methicillin-resistant Staphylococcus aureus clinical strains from the endotracheal tubes of patients with nosocomial pneumonia, Antimicrob. Resist. Infect. Control, 9, 43, 10.1186/s13756-020-0679-z · DOI
- Schwarz, 2006, Antimicrobial resistance of coagulase-negative staphylococci from bovine subclinical mastitis with particular reference to macrolide–lincosamide resistance phenotypes and genotypes, J. Antimicrob. Chemother., 57, 966, 10.1093/jac/dkl061 · DOI · Paper page
- Phaku, 2016, Unveiling the molecular basis of antimicrobial resistance in Staphylococcus aureus from the Democratic Republic of the Congo using whole genome sequencing, Clin. Microbiol. Infect., 22, 644.e1, 10.1016/j.cmi.2016.04.009 · DOI
- Akpaka, 2017, Molecular characterization of antimicrobial resistance genes against Staphylococcus aureus isolates from Trinidad and Tobago, J. Infect. Public Health, 10, 316, 10.1016/j.jiph.2016.05.010 · DOI
- Osman, 2015, Characterization of resistance genes to macrolides, lincosamides and streptogramins (MLS) among clinical isolates of Staphylococcus aureus in North Lebanon, Int. Arab. J. Antimicrob. Agents, 5, 3
- Schwarz, 2007, Molecular basis of resistance to macrolides and lincosamides among staphylococci and streptococci from various animal sources collected in the resistance monitoring program BfT-GermVet, Int. J. Antimicrob. Agents, 29, 528, 10.1016/j.ijantimicag.2006.12.016 · DOI
- Schwarz, 2016, Lincosamides, streptogramins, phenicols, and pleuromutilins: Mode of action and mechanisms of resistance, Cold Spring Harb. Perspect. Med., 6, a027037, 10.1101/cshperspect.a027037 · DOI
- Liang, 2019, Antimicrobial resistance, virulence genes profiling and molecular relatedness of methicillin-resistant Staphylococcus aureus strains isolated from hospitalized patients in Guangdong Province, China, Infect. Drug Resist., 12, 447, 10.2147/IDR.S192611 · doi:10.2147/idr.s192611
- Ceballos, S., Lozano, C., Aspiroz, C., Ruiz-Ripa, L., Eguizábal, P., Campaña-Burguet, A., Cercenado, E., López-Calleja, A.I., Castillo, J., and Azcona-Gutiérrez, J.M. (2022). Beyond CC398: Characterisation of Other Tetracycline and Methicillin-Resistant Staphylococcus aureus Genetic Lineages Circulating in Spanish Hospitals. Pathogens, 11. · DOI
- Yebra, 1991, The effect of sinefungin and synthetic analogues on RNA and DNA methyltransferases from Streptomyces, J. Antibiot., 44, 1141, 10.7164/antibiotics.44.1141 · doi:10.7164/antibiotics.44.1141
- Miranda, 2009, DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation, Mol. Cancer Ther., 8, 1579, 10.1158/1535-7163.MCT-09-0013 · DOI · Paper page
- Barbes, 1990, Effects of sinefungin and S-adenosylhomocysteine on DNA and protein methyltransferases from Streptomyces and other bacteria, FEMS Microbiol. Lett., 69, 239, 10.1111/j.1574-6968.1990.tb04237.x · doi:10.1111/j.1574-6968.1990.tb04237.x
- Schluckebier, 1999, The 2.2 Å structure of the rRNA methyltransferase ErmC′ and its complexes with cofactor and cofactor analogs: Implications for the reaction mechanism, J. Mol. Biol., 289, 277, 10.1006/jmbi.1999.2788 · DOI
- Svetlov, 2021, Structure of Erm-modified 70S ribosome reveals the mechanism of macrolide resistance, Nat. Chem. Biol., 17, 412, 10.1038/s41589-020-00715-0 · DOI
- Dunkle, 2010, Structures of the Escherichia coli ribosome with antibiotics bound near the peptidyl transferase center explain spectra of drug action, Proc. Natl. Acad. Sci. USA, 107, 17152, 10.1073/pnas.1007988107 · DOI · Paper page
- Lando, 1976, Paromomycin and dihydrostreptomycin binding to Escherichia coli ribosomes, Eur. J. Biochem., 66, 597, 10.1111/j.1432-1033.1976.tb10587.x · DOI
- Kleinzeller, A., Springer, G.F., and Wittmann, H.G. (1979). Inhibitors of Protein Biosynthesis, Springer. [30th ed.].
- Dahlberg, 1978, Interaction of neomycin with ribosomes and ribosomal ribonucleic acid, Antimicrob. Agents Chemother., 13, 331, 10.1128/AAC.13.2.331 · doi:10.1128/aac.13.2.331
- Sharkey, 2016, ABC-F proteins mediate antibiotic resistance through ribosomal protection, MBio, 7, e01975–e15, 10.1128/mBio.01975-15 · DOI · Paper page
- Gibbons, 2003, A novel inhibitor of multidrug efflux pumps in Staphylococcus aureus, J. Antimicrob. Chemother., 51, 13, 10.1093/jac/dkg044 · DOI · Paper page
- Gibbons, 2004, Anti-staphylococcal plant natural products, Nat. Prod. Rep., 21, 263, 10.1039/b212695h · DOI · Paper page
- Maton, 1991, Omeprazole, N. Engl. J. Med., 324, 965, 10.1056/NEJM199104043241406 · doi:10.1056/nejm199104043241406
- 2004, Lincomycin, clindamycin and their applications, Appl. Microbiol. Biotechnol., 64, 455, 10.1007/s00253-003-1545-7 · DOI · Paper page
- Lee, H.J., Jhang, S.T., and Jin, H.J. (2021). Potential Target Site for Inhibitors in MLSB Antibiotic Resistance. Antibiotics, 10. · doi:10.3390/antibiotics10030264
- Steward, 2005, Testing for induction of clindamycin resistance in erythromycin-resistant isolates of Staphylococcus aureus, J. Clin. Microbiol., 43, 1716, 10.1128/JCM.43.4.1716-1721.2005 · DOI · Paper page
- Williams, 1990, DNA polymorphisms amplified by arbitrary primers are useful as genetic markers, Nucleic Acids Res., 18, 6531, 10.1093/nar/18.22.6531 · DOI · Paper page
- Tintino, 2017, Tannic acid affects the phenotype of Staphylococcus aureus resistant to tetracycline and erythromycin by inhibition of efflux pumps, Bioorg. Chem., 74, 197, 10.1016/j.bioorg.2017.08.004 · DOI
- Cetin, 2013, Determination of in vitro activities of polymyxin B and rifampin in combination with ampicillin/sulbactam or cefoperazone/sulbactam against multidrug-resistant Acinetobacter baumannii by the E-test and checkerboard methods, Jpn. J. Infect. Dis., 66, 463, 10.7883/yoken.66.463 · DOI
- Hsieh, 1993, Synergy assessed by checkerboard a critical analysis, Diagn. Microbiol. Infect. Dis., 16, 343, 10.1016/0732-8893(93)90087-N · DOI · Paper page
- EUCAST (2000). Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents. Clin. Microbiol. Infect., 6, 503–508. · DOI · Paper page
- Vilar, 2008, Medicinal chemistry and the molecular operating environment (MOE): Application of QSAR and molecular docking to drug discovery, Curr. Top. Med. Chem., 8, 1555, 10.2174/156802608786786624 · DOI · Paper page
- Matsuoka, 1998, A plasmid that encodes three genes for resistance to macrolide antibiotics in Staphylococcus aureus, FEMS Microbiol. Lett., 167, 221, 10.1111/j.1574-6968.1998.tb13232.x · DOI
- Strommenger, 2003, Multiplex PCR assay for simultaneous detection of nine clinically relevant antibiotic resistance genes in Staphylococcus aureus, J. Clin. Microbiol., 41, 4089, 10.1128/JCM.41.9.4089-4094.2003 · DOI · Paper page
- Leclercq, 1989, Selection of constitutive mutants of gram-positive cocci inducible resistant to macrolides, lincosamides and streptogramins (MLS): Comparison of the selective effects of the MLS, Pathol. Biol., 37, 568
- Ross, 1990, Inducible erythromycin resistance in staphlyococci is encoded by a member of the ATP-binding transport super-gene family, Mol. Microbiol., 4, 1207, 10.1111/j.1365-2958.1990.tb00696.x · DOI · Paper page
- Bozdogan, 1999, A new resistance gene, linB, conferring resistance to lincosamides by nucleotidylation in Enterococcus faecium HM1025, Antimicrob. Agents Chemother., 43, 925, 10.1128/AAC.43.4.925 · DOI · Paper page
- Sutcliffe, 1996, Detection of erythromycin-resistant determinants by PCR, Antimicrob. Agents Chemother., 40, 2562, 10.1128/AAC.40.11.2562 · DOI · Paper page
- Allignet, 1992, Sequence of a staphylococcal plasmid gene, vga, encoding a putative ATP-binding protein involved in resistance to virginiamycin A-like antibiotics, Gene, 117, 45, 10.1016/0378-1119(92)90488-B · DOI
- Loncle, 1993, Analysis of pristinamycin-resistant Staphylococcus epidermidis isolates responsible for an outbreak in a Parisian hospital, Antimicrob. Agents Chemother., 37, 2159, 10.1128/AAC.37.10.2159 · doi:10.1128/aac.37.10.2159
- Hammerum, 1998, Detection of the satA gene and transferability of virginiamycin resistance in Enterococcus faecium from food-animals, FEMS Microbiol. Lett., 168, 145, 10.1111/j.1574-6968.1998.tb13267.x · DOI
- Allignet, 1998, Characterization of a staphylococcal plasmid related to pUB110 and carrying two novel genes, vatC and vgbB, encoding resistance to streptogramins A and B and similar antibiotics, Antimicrob. Agents Chemother., 42, 1794, 10.1128/AAC.42.7.1794 · DOI
Cited by
Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms
Touaitia, R., Mairi, A., Ibrahim, N. A., Basher, N. S., Idres, T., & Touati, A. (2025) · Antibiotics · doi:10.3390/antibiotics14050470 · Cited by 273
Metadata
- Authors
- Mahfouz, A. A., Said, H. S., Elfeky, S. M., & Shaaban, M. I.
- Venue
- Antibiotics
- Publisher
- MDPI AG
- Published
- 2023-03-02
- Volume
- 12
- Issue
- 3
- Pages
- 503
- ISSN
- 2079-6382
- Cited by
- 34
- References
- 3
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibition of Erythromycin and Erythromycin-Induced Resistance among Staphylococcus aureus Clinical Isolates. https://app.cochat.ai/papers/10.3390/antibiotics12030503
- The paper
- Mahfouz, A. A., Said, H. S., Elfeky, S. M., & Shaaban, M. I. (2023). Inhibition of Erythromycin and Erythromycin-Induced Resistance among Staphylococcus aureus Clinical Isolates. Antibiotics. https://doi.org/10.3390/antibiotics12030503
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.